While they can be fatal upon rupture or dissection, ascending thoracic aortic aneurysms are also associated with apparent protection against atherosclerosis.
Treatment with warfarin early after bioprosthetic surgical aortic valve replacement is associated with lower mortality and thromboembolism risk but increased major bleeding events.
Women undergoing percutaneous coronary intervention who receive abbreviated rather than standard dual antiplatelet therapy have similar outcomes to men despite higher baseline risk.